Cancer Blog

Here's our collection of cancer-related stories. We sift through a variety of stories and share the issues that we think matter to cancer patients, caregivers, healthcare providers and survivors. Learn about current events in the cancer community, human interest stories, and promising technology and treatment advances. Tell us what you think in the Comments section at the bottom of each post.

Note: The information contained in this service is not intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition. Nothing contained in the service is intended to be used for medical diagnosis or treatment of any illness, condition or disease.

Jul

06

Permalink Comment RSS (1)

Clinical Trial Results of Motesanib's Effectiveness Against MTC

by: cancercompass

The drug motesanib has been found to help stabilize patients with medullary thyroid cancer (MTC). The supporting research was published recently in the Journal of Clinical Oncology.

Researchers analyzed 91 patients with advanced or metastatic, progressive or symptomatic MTC after receiving motesanib orally for up to 48 weeks. Treatments were stopped for patients experiencing unacceptable toxicity levels or disease progression.

The study abstract reports that 81% of patients who received motesanib achieved a stable disease state. In addition, 76% of patients saw a decrease in tumor size from baseline measurements.

Commonly experienced side effects were diarrhea, fatigue, hypothyroidism, hypertension and anorexia.

Are you currently taking part in clinical trials like this one? Help other cancer patients learn from your experiences at our Clinical Trials and Research Cancer Forum.

 

Jul

06

Permalink Comment RSS (0)

New Gene Raises Testicular Cancer Risk

by: cancercompass

Doctors have discovered a second gene that raises a man's risk for inheriting a common testicular cancer, reports the National Institutes of Health (NIH).

Heredity plays a role in testicular germ-cell cancer say scientists who believe multiple genes acting together influence a man's risk, explains NIH in a recent press release.  Doctors discovered several mutations of the gene PDE11A. Disruptions to this gene's enzyme do not directly cause cancer but do increase a person's likelihood of developing a tumor.

The study appears online in Cancer Research.
 
Have doctors said genetics play a role in your specific form of testicular cancer? Share your experiences with other cancer patients and survivors at the Testicular Cancer Message Board.

 

Jul

06

Permalink Comment RSS (0)

Pond Scum May Help Kill Cancer Cells

by: cancercompass

Molecular Biologist Elizabeth Blackburn's research on tetrahymena, one-celled organisms known as pond scum, may prove to be an important factor in the fight against cancer.

In a recent interview with U.S. News & World Report, Blackburn discusses telomerase, the enzyme Blackburn co-discovered that keeps pond scum's genetic makeup from eroding. Constant production of the telomerase enzyme keeps cells alive.

According to Blackburn, cancer cells have high levels of telomerase, which can be poisoned by mutant gene variations causing the cancer cells to "curl up their toes and die."

Blackburn sees potential in her research, especially considering that 90% of human cancers involve telomerase.  However, human trials of the procedure are a long ways off.

What are your thoughts about the role of genetics in the fight against cancer? Share your thoughts on our Genetics Message Board.

 

We care about your feedback. Let us know how we can improve your CancerCompass experience.